Audet & Partners Successfully Deal with Cases Regarding GranuFlo Heart Attacks
The U.S. Food & Drug Administration (FDA) has recently announced a Class I recall against GranuFlo and NaturaLyte Dialysis product suppliers, Fresenius Medical Care. The declaration was made on behalf of an internal memo from Fresenius, warning customers against using that particular product.
View full press release